APA (7th ed.) Citation

Hirano, I., Dellon, E. S., Pellegatta, G., Xia, C., Pela, T., Durrani, S., . . . Radwan, A. (2024). Sa1257 DUPILUMAB IMPROVES INFLAMMATORY AND REMODELING ASPECTS OF ENDOSCOPIC DISEASE ACTIVITY IN EOSINOPHILIC ESOPHAGITIS: 52-WEEK RESULTS FROM THE PHASE 3 LIBERTY EOE TREET STUDY. Gastroenterology (New York, N.Y. 1943), 166(5), S-402-S-403. https://doi.org/10.1016/S0016-5085(24)01409-4

Chicago Style (17th ed.) Citation

Hirano, Ikuo, Evan S. Dellon, Gaia Pellegatta, Changming Xia, Tiffany Pela, Sandy Durrani, Juby A. Jacob-Nara, and Amr Radwan. "Sa1257 DUPILUMAB IMPROVES INFLAMMATORY AND REMODELING ASPECTS OF ENDOSCOPIC DISEASE ACTIVITY IN EOSINOPHILIC ESOPHAGITIS: 52-WEEK RESULTS FROM THE PHASE 3 LIBERTY EOE TREET STUDY." Gastroenterology (New York, N.Y. 1943) 166, no. 5 (2024): S-402-S-403. https://doi.org/10.1016/S0016-5085(24)01409-4.

MLA (9th ed.) Citation

Hirano, Ikuo, et al. "Sa1257 DUPILUMAB IMPROVES INFLAMMATORY AND REMODELING ASPECTS OF ENDOSCOPIC DISEASE ACTIVITY IN EOSINOPHILIC ESOPHAGITIS: 52-WEEK RESULTS FROM THE PHASE 3 LIBERTY EOE TREET STUDY." Gastroenterology (New York, N.Y. 1943), vol. 166, no. 5, 2024, pp. S-402-S-403, https://doi.org/10.1016/S0016-5085(24)01409-4.